scholarly journals Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study

Author(s):  
Zhen-Yu Wu ◽  
Jing Han ◽  
Hee Jeong Kim ◽  
Jong Won Lee ◽  
Il Yong Chung ◽  
...  
2021 ◽  
Author(s):  
Zhen-Yu Wu ◽  
Jing Han ◽  
Hee Jeong Kim ◽  
Jong Won Lee ◽  
Il Yong Chung ◽  
...  

Abstract Purpose A large proportion of patients with breast cancer who had mastectomy had undergone breast reconstruction with implants or autologous flaps. However, only a few studies have compared the breast cancer outcomes between the implant-based reconstruction (IBR) and autologous flap reconstruction (AFR). In this study, we retrospectively compared the local recurrence rates, distant metastasis rates, and survival outcomes between immediate IBR and AFR. Methods A total of 1530 patients with primary breast cancer who underwent IBR or AFR with nipple-/skin-sparing mastectomy were included. Patients who underwent neoadjuvant systemic therapy were excluded from the study. After propensity score matching by age at diagnosis, T stage, N stage, molecular subtype, mastectomy type, adjuvant radiotherapy status, and follow-up period, 938 patients were 1:1 matched, comprising the well-balanced IBR and AFR groups. Locoregional recurrence-free survival (LRRFS), disease-free survival (DFS), distant metastasis-free survival (DMFS), and breast cancer-specific survival (BCSS) were compared between the matched groups. Results After matching, the median follow-up periods were 68 months and 71 months for the IBR and AFR groups, respectively. No significant differences were observed between the IBR and AFR groups regarding the local recurrence (7.2% vs. 5.1%; P = 0.175), regional recurrence (2.1% vs. 1.5%; P = 0.463), or distant metastasis (3.2% vs. 3.2%; P = 1.000) rates. Moreover, no significant difference was observed between the IBR and AFR groups in the LRRFS (hazard ratio, 0.691; 95% CI, 0.433–1.102; P = 0.118), DFS (hazard ratio, 0.709; 95% CI, 0.468–1.076; P = 0.104), DMFS (hazard ratio, 1.006; 95% CI, 0.491–2.059; P = 0.987), or BCSS (hazard ratio, 0.445; 95% CI, 0.111–1.786; P = 0.659). Conclusion In this propensity score-matched analysis of oncologic outcomes in patients with primary breast cancer who underwent immediate breast reconstruction with nipple-/skin-sparing mastectomy, no significant differences were observed between the IBR and AFR groups.


2018 ◽  
Vol 25 (10) ◽  
pp. 3096-3105 ◽  
Author(s):  
Brice Jabo ◽  
Ann C. Lin ◽  
Mayada A. Aljehani ◽  
Liang Ji ◽  
John W. Morgan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document